Cargando…
Correction to Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial
Autores principales: | Wang, Hai, Agarwal, Pranay, Zhao, Gang, Ji, Guang, Jewell, Christopher M., Fisher, John P., Lu, Xiongbin, He, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161482/ https://www.ncbi.nlm.nih.gov/pubmed/34079906 http://dx.doi.org/10.1021/acscentsci.1c00530 |
Ejemplares similares
-
Overcoming Ovarian Cancer Drug Resistance with a Cold
Responsive Nanomaterial
por: Wang, Hai, et al.
Publicado: (2018) -
Retraction of
“Overcoming Ovarian Cancer Drug
Resistance with a Cold Responsive Nanomaterial”
por: Wang, Hai, et al.
Publicado: (2023) -
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
por: Wang, Hai, et al.
Publicado: (2018) -
Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents
por: Wang, Hai, et al.
Publicado: (2016) -
A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of therasnostic agents
por: Wang, Hai, et al.
Publicado: (2015)